Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/19464823

Int. J. Radiat. Oncol. Biol. Phys. 2010 Mar 1 76 3 824-30

Download in:

View as

General Info

PMID
19464823